June 5, 2014 — Magnetic resonance-guided focused ultrasound (MRgFUS) using the Exablate system by Insightec Ltd. (based in Tirat Carmel, Israel) is a relatively new noninvasive thermal ablation option, U.S. Food and Drug Administration (FDA)-approved for treating and palliating pain from bone metastases. The technology integrates high-intensity focused ultrasound and a real-time magnetic resonance imaging (MRI) system in one unit.

June 5, 2014 — The American Society for Radiation Oncology (ASTRO) has garnered a record-breaking total of 2,874 abstracts submitted for selection for the 56th annual meeting. The scientific presentations will include up to four plenary papers, 360 oral presentations, 1,862 posters and 144 digital posters in more than 50 educational sessions and for 20 disease-site tracks and topics including radiation biology, radiation physics, palliative care, patient safety and patient-reported outcomes.

June 5, 2014 — A team of researchers at the University of Texas Health Science Center at Houston (UTHealth) Medical School has developed a new technology that can noninvasively image the human lymphatic system (also known as “lymphatics”). A fluorescent dye and commercially available laser diode and military-grade night vision devices were used to visualize the lymphatic capillaries.

Siemens Symbia Intevo

June 5, 2014 — Fairview Health Services, Minneapolis, recently became the first U.S. healthcare facility to install the Symbia Intevo xSPECT system from Siemens Healthcare. The first ever xSPECT system, the Symbia Intevo fully integrates single-photon emission computed tomography (SPECT) and CT during image reconstruction, combining SPECT’s high sensitivity with the high specificity of CT and completely integrating data from the two modalities to generate high resolution and, for the first time, quantitative images.
Molecular Breast Imaging Coverage Dilon Technologies Mammography

When a health insurance company denies a claim, most people complain to their friends and family and then accept it, arranging payment methods or even denying themselves a procedure that may save their life. However, one patient decided to fight back and challenge her insurance carrier.

The American Society for Radiation Oncology (ASTRO) has issued a new model policy for proton beam therapy (PBT) that details which cancer diagnoses meet ASTRO’s evidence-based standards and should be covered by private insurers and Medicare.

Fortress Introducer Sheath

The U.S. Food and Drug Administration (FDA) recently cleared BB Medical Surgical’s Thixo-Gel, which is sprayed on to the patient to enable quicker and easier ultrasound scans. 

Olympus announced the commercial availability of its U.S. Food and Drug Administration (FDA) 510(k)-cleared, next-generation BF-P190 and BF-XP190 bronchoscopes for peripheral and small anatomy bronchoscopy.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now